Apyx Medical Corporation Reports Third Quarter 2026 Financial Results
CLEARWATER, Fla., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body Contouring System ™ (AYON), today reported financial results for its third quarter ended September 30, 2026.
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


